Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.256
-$0.005-1.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.14% | 198.01% | 33.69% | 28.20% | -10.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.53% | 90.83% | 1.16% | -10.36% | 73.16% |
| Operating Income | -38.53% | -90.83% | -1.16% | 10.36% | -73.16% |
| Income Before Tax | 2.56% | -111.07% | 7.01% | -77.52% | -118.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.56% | -111.07% | 7.01% | -77.52% | -118.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.56% | -111.07% | 7.01% | -77.52% | -118.47% |
| EBIT | -38.53% | -90.83% | -1.16% | 10.36% | -73.16% |
| EBITDA | -38.61% | -91.00% | -1.20% | 10.39% | -73.24% |
| EPS Basic | 60.23% | -74.40% | 21.36% | -45.76% | -66.64% |
| Normalized Basic EPS | 61.48% | -42.57% | 0.93% | -37.25% | -72.08% |
| EPS Diluted | 51.09% | -74.40% | 21.36% | -45.76% | -66.64% |
| Normalized Diluted EPS | 61.48% | -42.57% | 0.93% | -37.25% | -72.08% |
| Average Basic Shares Outstanding | 145.00% | 21.03% | 18.24% | 21.78% | 31.12% |
| Average Diluted Shares Outstanding | 145.00% | 21.03% | 18.24% | 21.78% | 31.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |